Trending...
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
PHILADELPHIA, June 14, 2024 ~ A team of researchers at Children's Hospital of Philadelphia (CHOP) has made a groundbreaking discovery that could potentially save the lives of millions of women. The team, led by core faculty member Bo Li, PhD, has identified a novel immune-based biomarker that could lead to early detection of high-grade ovarian cancer (HGOC).
According to the press release from CHOP, HGOC is the fifth-leading cause of cancer-related death among women. The disease is often diagnosed in its advanced stages when it has already spread, making treatment challenging. However, with the discovery of this new biomarker, there is hope for earlier detection and intervention.
Dr. Li emphasized the importance of early detection in saving lives. "Early detection of ovarian cancer could mean the difference between life and death for millions of women," he said.
The study, published in Cell Reports Medicine, analyzed T-cell receptors (TCRs) in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer and healthy controls from the Nurses' Health Study. TCRs are proteins found on immune cells that recognize and bind to foreign substances.
More on The PennZone
The researchers found that in the early stages of HGOC, approximately two to four years before most cases are currently diagnosed, there is a significant increase in TCR activity. This suggests that tracking changes in TCRs could be an effective way to detect the disease before it progresses.
However, further research is needed to develop a diagnostic test sensitive enough to detect this novel immune biomarker. The team envisions this test as a complement to current approved screening protocols for HGOC.
The study was supported by grants from the National Cancer Institute and sample collection was partially supported by UT Southwestern Medical Center's Department of Obstetrics and Gynecology.
CHOP's comprehensive Research Institute is dedicated to improving children's lives and helping them thrive into adulthood through transformative solutions like this new biomarker discovery. By tackling pressing healthcare challenges, CHOP is also making strides in improving wellness beyond pediatrics across the entire lifespan.
The team's findings have the potential to not only improve early detection of HGOC but also advance pediatric cancer research. The study, titled "Quantifiable TCR repertoire changes in pre-diagnostic blood specimens among patients with high-grade ovarian cancer," was published online on June 14, 2024, and can be found in Cell Reports Medicine.
According to the press release from CHOP, HGOC is the fifth-leading cause of cancer-related death among women. The disease is often diagnosed in its advanced stages when it has already spread, making treatment challenging. However, with the discovery of this new biomarker, there is hope for earlier detection and intervention.
Dr. Li emphasized the importance of early detection in saving lives. "Early detection of ovarian cancer could mean the difference between life and death for millions of women," he said.
The study, published in Cell Reports Medicine, analyzed T-cell receptors (TCRs) in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer and healthy controls from the Nurses' Health Study. TCRs are proteins found on immune cells that recognize and bind to foreign substances.
More on The PennZone
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- CLASS ACTION REMINDER: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025
- Colbert Packaging Announces WBENC Recognition
- SHI Cryogenics Group Launches Highest-Capacity Single-Stage Cryocoolers to Date
The researchers found that in the early stages of HGOC, approximately two to four years before most cases are currently diagnosed, there is a significant increase in TCR activity. This suggests that tracking changes in TCRs could be an effective way to detect the disease before it progresses.
However, further research is needed to develop a diagnostic test sensitive enough to detect this novel immune biomarker. The team envisions this test as a complement to current approved screening protocols for HGOC.
The study was supported by grants from the National Cancer Institute and sample collection was partially supported by UT Southwestern Medical Center's Department of Obstetrics and Gynecology.
CHOP's comprehensive Research Institute is dedicated to improving children's lives and helping them thrive into adulthood through transformative solutions like this new biomarker discovery. By tackling pressing healthcare challenges, CHOP is also making strides in improving wellness beyond pediatrics across the entire lifespan.
The team's findings have the potential to not only improve early detection of HGOC but also advance pediatric cancer research. The study, titled "Quantifiable TCR repertoire changes in pre-diagnostic blood specimens among patients with high-grade ovarian cancer," was published online on June 14, 2024, and can be found in Cell Reports Medicine.
Filed Under: Business
0 Comments
Latest on The PennZone
- Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft
- Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- LDR Partners LP Announces Acquisition of Active Radiator, and Combination with Cincinnati Radiator and Ohio Heat Transfer, Forming the Largest U.S. Heavy Manufacturing Platform for Aluminum Industrial Heat Exchangers
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
- Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
- Sidney and Caroline Kimmel Invest in the Future of Care and Discovery at Jefferson
- Abide Capital Acquires Columbus, OH Apartment Community for $16.5 Million
- Miami Real Estate Agent Drastically Increases Interest In Homes
- Adostics & Genmega Announce the Introduction of A-POD
- QVC Kicks Off 'Christmas in July' with Star-Studded Merrymakers Lineup: Elton John, Martha Stewart, Kathy Hilton, Kim Gravel and Babs Costello as Chief Cheer Officer
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
- The Waite Launches: A Curated Motherhood Marketplace For Every Stage
- Affordable, High-Quality Care: Cheap Braces for Adults Available from Exeter Smiles in Reading
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Sci-Fi Novel from Pittsburgh Author Explores Love, Power, & Humanity in an Age of Artificial People
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media